CONVERTIBLE PREFERRED STOCK AND WARRANT SECURITIES PURCHASE AGREEMENTConvertible Preferred Stock and Warrant Securities Purchase Agreement • July 20th, 2020 • AzurRx BioPharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 20th, 2020 Company Industry JurisdictionThis Convertible Preferred Stock and Warrant Securities Purchase Agreement, dated as of July 16, 2020 (this “Agreement”), is entered into by and among AzurRx BioPharma, Inc., a Delaware corporation (the “Company”), and the other signatories hereto (each an “Investor” and collectively, the “Investor”).